Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Use of Neoadjuvant Vandetanib in Aggressive Pediatric Medullary Thyroid Carcinoma. JCO precision oncology Kothari, R., Kreimer, S., Nadel, H., Seeley, H., Hartman, G., Meister, K. D. 2024; 8: e2300257
Abstract
Novel use of vandetanib in a child with aggressive MTC with prolonged response to treatment.
View details for DOI 10.1200/PO.23.00257
View details for PubMedID 38207224